IPOs

Newly merged Mereo BioPharma looks to OncoMed for R&D hires
Newly merged Mereo BioPharma looks to OncoMed for R&D hires
Fierce Biotech
Mereo BioPharma
IPOs
OncoMed
R&D
Flag link:
The biotech IPO boom is becoming ‘historic’ as four more throw their hats in
The biotech IPO boom is becoming ‘historic’ as four more throw their hats in
Endpoints
IPOs
biotech
Berkeley Lights
ALX Oncology
Pandion Therapeutics
Kiromic Biopharma
Flag link:
Relay Lays $200M IPO Plan to Fund Tests of Protein Motion Cancer Drugs
Relay Lays $200M IPO Plan to Fund Tests of Protein Motion Cancer Drugs
Xconomy
Relay Therapeutics
IPOs
protein motion
cancer
Flag link:
After filing for IPO, ArcherDX agrees to $1.4B buyout by Invitae
After filing for IPO, ArcherDX agrees to $1.4B buyout by Invitae
MedCity News
ArcherDX
M&A
IPOs
cancer
Invitae
Flag link:
Meet the Pharma Company That Just Had a Bigger IPO Than Moderna's
Meet the Pharma Company That Just Had a Bigger IPO Than Moderna's
Motley Fool
IPOs
Moderna Therapeutics
Royalty Pharma
Flag link:
Poseida Therapeutics guns again for IPO
Poseida Therapeutics guns again for IPO
Fierce Biotech
Poseida Therapeutics
CAR-T
IPOs
Flag link:
The biotech IPOs keep coming at chart-topping levels — with no slowdown in sight
The biotech IPOs keep coming at chart-topping levels — with no slowdown in sight
Endpoints
biotech
IPOs
Repare Therapeutics
Forma Therapeutics
Avidity Biosciences
Vaxcyte
SK Biopharmaceuticals
Generation Bio
Royalty Pharma
Flag link:
4DMT to Use $75 Million Series C to Advance Three Key Pipeline Products
4DMT to Use $75 Million Series C to Advance Three Key Pipeline Products
BioSpace
4D Molecular Therapeutics
IPOs
gene therapy
Flag link:
Royalty Pharma scores $2.2B IPO — the biggest of the year
Royalty Pharma scores $2.2B IPO — the biggest of the year
Endpoints
Royalty Pharma
IPOs
NASDAQ
Flag link:
SK Biopharmaceuticals emerges from pandemic delays with pitch for $822M IPO
SK Biopharmaceuticals emerges from pandemic delays with pitch for $822M IPO
Endpoints
SK Biopharmaceuticals
South Korea
IPOs
Flag link:
Could This Recent IPO Biotech Become the Next Moderna?
Could This Recent IPO Biotech Become the Next Moderna?
Motley Fool
Pliant Therapeutics
IPOs
Moderna Therapeutics
fibrotic disease
Flag link:
The pandemic IPOs keep rolling, as Generation, Avidity, Vaxcyte each claim 200M+
The pandemic IPOs keep rolling, as Generation, Avidity, Vaxcyte each claim 200M+
Endpoints
biotech
IPOs
Generation Bio
Avidity Biosciences
Vaxcyte
Burning Rock
Flag link:
Two preclinical biotechs riding the IPO wave this week look to raise $466M-plus
Two preclinical biotechs riding the IPO wave this week look to raise $466M-plus
Endpoints
IPOs
Avidity Biosciences
Generation Bio
Flag link:
Royalty Pharma plans largest IPO of the year so far
Royalty Pharma plans largest IPO of the year so far
Pharmaforum
Royalty Pharma
IPOs
NASDAQ
Flag link:
Add ear gene therapy company Akouos to the ever-growing list of IPOs amid Covid-19
Add ear gene therapy company Akouos to the ever-growing list of IPOs amid Covid-19
Endpoints
IPOs
Akouos
NASDAQ
gene therapy
hearing loss
Flag link:
Fresh off ASCO myeloma data, Legend Bio gets $424M in biotech's biggest IPO of 2020
Fresh off ASCO myeloma data, Legend Bio gets $424M in biotech's biggest IPO of 2020
BioPharma Dive
Legend Biotech
IPOs
cancer
cell therapies
ASCO 2020
Flag link:
Report: Amwell confidentially files for IPO
Report: Amwell confidentially files for IPO
MedCity News
Amwell
telehealth
COVID-19
pandemic
IPOs
Flag link:
Biotech IPOs near last year's pace, despite COVID-19 pandemic
Biotech IPOs near last year's pace, despite COVID-19 pandemic
BioPharma Dive
IPOs
biotech
Pliant Therapeutics
Legend Biotech
Flag link:
Biotech IPO bonanza: Legend's $350M offering as Repare, Forma get in on the action
Biotech IPO bonanza: Legend's $350M offering as Repare, Forma get in on the action
Fierce Biotech
Legend Biotech
IPOs
GenScript
NASDAQ
Flag link:
IPOs abound in the time of coronavirus, as Forma Therapeutics pencils in $150M Nasdaq debut
IPOs abound in the time of coronavirus, as Forma Therapeutics pencils in $150M Nasdaq debut
Endpoints
IPOs
NASDAQ
Forma Therapeutics
Bristol-Myers Squibb
COVID-19
Flag link:

Pages